Elix
Business Services · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8-34 Yonbancho 3F, Yonbanchou, Tokyo, 10...Phone Number
(289) 813-4623Website
www.elix-inc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Elix
Elix, Inc. is an AI-driven drug discovery company that rethinks traditional drug development by leveraging artificial intelligence to enhance successful outcomes. Their platform offers a comprehensive suite of tools, including predictive and generative models, along with expert consulting to support medicinal chemists. Elix collaborates with pharmaceutical companies, academic institutions, and drug discovery start-ups, emphasizing openness and knowledge sharing in their research efforts. The company aims to propose innovative drug structures that go beyond conventional approaches, ensuring a higher success rate in collaborative research.Explore more
Elix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Elix recently announced quarterly report
Funding: Get notified immidiatlly once Elix has new funding data
Elix, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Elix
Check if Elix has recently received funding, and reach out quickly before it becomes old news!
Click to see if Elix had a recent Job posting/layoffs
Product Launch: Get notified when Elix launches new products
Check out if Elix is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Elix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Elix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Elix.
Elix Tech Stack
A closer look at the technologies used by Elix
See more technologies
Elix News & Media
Elix Provides AI Drug Discovery Platform "Elix Discovery™" to KYORIN Pharmaceutical
TOKYO, JAPAN, August 20, 2025 /EINPresswire.com/ -- Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”), a Japan-based AI drug discovery company, is pleased to announce that KYORIN Pharmaceutical Co., Ltd. (Headquarters: Tokyo; …Elix and LINC Become the First in the World to Commercialize an AI Drug Discovery Platform Incorporating Federated Learning-Based AI Models Trained on Data from 16 Pharmaceutical Companies
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo, hereinafter “Elix”), an AI drug discovery company with the mission of "Rethinking Drug Discovery” and the Life Intelligence Consortium (Representative Director: Yasushi Okuno / Headquarters: Osaka, hereinafter “LINC”) are pleased to announce that for the first time in the world we have commercialized an AI drug discovery platform that incorporates multiple AI models trained using federated learning on data provided by 1PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platform TOKYO, April 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a drug discovery collaboration with Elix, Inc. ("Elix"), effective April 1, 2025.AI Drug Discovery Company Elix Commences Joint Research With Proprietary Screening Technology Holder SEEDSUPPLY
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / HQ: Tokyo, hereinafter “Elix”) and SEEDSUPPLY Inc. (CEO: Naoki Tarui / HQ: Kanagawa, hereinafter “SEEDSUPPLY”) hereby announce the start of joint research. SEEDSUPPLY (https: //www.seedsupply.co.jp/) proposes an agile drug discovery process for small molecules that uses binder selection technology as a proprietary compound screening method. This technology can perform compound screening of any protein or RNA, thereby providing drug discover
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elix
Sign Up For FreeTo access detailed company insights
Elix, Inc. is an AI-driven drug discovery company that rethinks traditional drug development by leveraging artificial intelligence to enhance successful outcomes. Their platform offers a comprehensive suite of tools, including predictive and generative models, along with expert consulting to support medicinal chemists. Elix collaborates with pharma... Read More
